1320 Eribulin mesylate in metastatic breast cancer, a focus...

European Journal of Cancer 2015 / 09 Vol. 51

1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort

Martin-babau, J., Robert, M., Septans, A.L., Paillard, M.J., Pivot, X., Soibinet, P., Gourmelon, C., Brunot, A., Lefeuvre-plesse, C., Korenbaum, C., Petit, T., Marquis, A., Bourgeois, H., Uwer, L., So
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30563-9
Date:
September, 2015
File:
PDF, 74 KB
english, 2015
Conversion to is in progress
Conversion to is failed